X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3315) 3315
Newspaper Article (594) 594
Newsletter (299) 299
Government Document (244) 244
Magazine Article (64) 64
Book Chapter (26) 26
Book / eBook (21) 21
Report (16) 16
Transcript (16) 16
Reference (12) 12
Trade Publication Article (9) 9
Dissertation (5) 5
Web Resource (5) 5
Paper (3) 3
Pamphlet (1) 1
Publication (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2450) 2450
hiv (1627) 1627
aids (1543) 1543
human immunodeficiency virus--hiv (1511) 1511
acquired immune deficiency syndrome--aids (1433) 1433
female (1149) 1149
male (1024) 1024
immunology (934) 934
infectious diseases (926) 926
vaccines (898) 898
aids vaccines (897) 897
adult (839) 839
research (809) 809
health aspects (751) 751
medical research (676) 676
infections (669) 669
clinical trials (624) 624
hiv infections - prevention & control (622) 622
hiv infection (617) 617
animals (607) 607
hiv infections - immunology (547) 547
acquired immune deficiency syndrome (546) 546
prevention (541) 541
infection (529) 529
vaccination (522) 522
medicine (514) 514
aids vaccines - immunology (509) 509
drug therapy (507) 507
middle aged (506) 506
human immunodeficiency virus (486) 486
immunization (482) 482
hiv infections - drug therapy (471) 471
public health (461) 461
aids vaccines - adverse effects (426) 426
hiv-1 - immunology (421) 421
risk factors (415) 415
viruses (413) 413
research article (411) 411
studies (396) 396
adolescent (385) 385
antiretroviral therapy (375) 375
analysis (370) 370
multidisciplinary sciences (369) 369
human-immunodeficiency-virus (366) 366
antiviral agents (359) 359
care and treatment (354) 354
medicine, research & experimental (347) 347
virology (345) 345
medicine, experimental (338) 338
science (322) 322
antiretroviral drugs (311) 311
young adult (311) 311
mortality (308) 308
children (297) 297
microbiology (294) 294
highly active antiretroviral therapy (291) 291
epidemiology (284) 284
immune response (281) 281
aids vaccines - administration & dosage (279) 279
hiv/aids (276) 276
tuberculosis (275) 275
drugs (270) 270
medicine, general & internal (265) 265
virus diseases (265) 265
anti-hiv agents - therapeutic use (261) 261
viral load (248) 248
antigens (246) 246
hiv-1 (243) 243
disease (238) 238
hiv infections - epidemiology (238) 238
proteins (237) 237
antibodies (232) 232
public, environmental & occupational health (231) 231
safety (229) 229
cancer (228) 228
immunogenicity (226) 226
hiv infections - virology (225) 225
risk (222) 222
patients (221) 221
vaccine (220) 220
hiv infections - complications (216) 216
t cells (216) 216
hiv patients (214) 214
lymphocytes (214) 214
immune system (213) 213
pregnancy (209) 209
cd4 lymphocyte count (208) 208
women (205) 205
viral infections (201) 201
aids vaccines - therapeutic use (200) 200
disease transmission (191) 191
pharmaceutical industry (190) 190
aids/hiv (189) 189
mice (189) 189
child (188) 188
biology (184) 184
pediatrics (184) 184
active antiretroviral therapy (182) 182
fda approval (176) 176
hepatitis (175) 175
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Robarts - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Media Commons - Microtexts (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Theses (1) 1
Online Resources - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Scarborough - Circulation Desk (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4591) 4591
French (15) 15
German (15) 15
Spanish (5) 5
Russian (4) 4
Portuguese (3) 3
Afrikaans (1) 1
Dutch (1) 1
Hebrew (1) 1
Italian (1) 1
Japanese (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS pathogens, ISSN 1553-7374, 2015, Volume 11, Issue 9, p. e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
ACTIVATION | RNA | PERSISTENCE | CD4(+) T-CELLS | MICROBIOLOGY | VIROLOGY | HISTONE DEACETYLASES | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | STEM-CELL | INFECTION | PARASITOLOGY | VIRAL RESERVOIR | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 48, pp. 5706 - 5712
Highlights • rHPIV3cp45 vaccine was immunogenic and well-tolerated in seronegative young children... 
Allergy and Immunology | Live-attenuated vaccine | Recombinant virus vaccine | Pediatric vaccine | Parainfluenza | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOGENICITY | MUTANTS | INFANTS | PROGRESS | IMMUNOLOGY | RESPIRATORY SYNCYTIAL VIRUS | Humans | Parainfluenza Vaccines - adverse effects | Child, Preschool | Infant | Male | Vaccination - adverse effects | Vaccines, Synthetic - immunology | Antibodies, Viral - blood | Respirovirus Infections - virology | Drug-Related Side Effects and Adverse Reactions - pathology | Parainfluenza Virus 3, Human - genetics | Vaccination - methods | Vaccines, Synthetic - adverse effects | Vaccines, Attenuated - administration & dosage | Female | Nasal Cavity - virology | Placebos - administration & dosage | Double-Blind Method | Vaccines, Synthetic - genetics | Parainfluenza Virus 3, Human - immunology | Parainfluenza Vaccines - genetics | Parainfluenza Vaccines - immunology | Respirovirus Infections - prevention & control | Drug-Related Side Effects and Adverse Reactions - epidemiology | Parainfluenza Vaccines - administration & dosage | Vaccines, Attenuated - immunology | Vaccines, Synthetic - administration & dosage | Vaccines, Attenuated - adverse effects | Vaccines, Attenuated - genetics | Virus diseases | AIDS vaccines | Safety and security measures | Children | Health aspects | Public health | Pediatrics | Hospitals | Illnesses | Respiratory diseases | Clinical trials | Ear diseases | Infections | Hospitalization | Vaccines | Age | Children & youth
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 11, p. e0206838
Background We evaluated the safety and immunogenicity of (i) an intradermal HIV-DNA regimen given with/without intradermal electroporation (EP) as prime and... 
HUMORAL IMMUNE-RESPONSES | ELECTROPORATION | DNA VACCINE | SAFETY | MULTIDISCIPLINARY SCIENCES | BROAD | TYPE-1 | HIV Antibodies - blood | Immunogenicity, Vaccine | HIV Infections - prevention & control | Vaccines, DNA - genetics | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Viral Vaccines - genetics | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Glucosides - immunology | Male | Administration, Cutaneous | Healthy Volunteers | Viral Vaccines - adverse effects | Vaccines, DNA - administration & dosage | AIDS Vaccines - adverse effects | Vaccinia virus - immunology | Young Adult | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Lipid A - immunology | Mozambique | Vaccination - methods | HIV Antibodies - immunology | Adult | Female | Tanzania | Electroporation | Immunization, Secondary - methods | Viral Vaccines - administration & dosage | HIV-1 - immunology | Vaccines, DNA - adverse effects | AIDS Vaccines - genetics | AIDS Vaccines - administration & dosage | Viral Vaccines - immunology | Antibodies, Neutralizing - blood | AIDS vaccines | Usage | Care and treatment | Adults | Health aspects | HIV infection | Risk factors | Laboratories | Vaccination | Clinical trials | Viruses | Lipids | Infections | DNA vaccines | Vaccines | Lipid A | Proteins | Randomization | Immunology | Gag protein | Acquired immune deficiency syndrome--AIDS | Audio frequencies | Safety engineering | Human immunodeficiency virus--HIV | Safety | Public health | Deoxyribonucleic acid--DNA | Enzyme-linked immunosorbent assay | Antigens | Medical research | Immunization | Immunoglobulins | Internal medicine | Envelope protein | Priming | Medicine | Glycoprotein gp160 | Hospitals | Infectious diseases | Immunogenicity | γ-Interferon | Glycoprotein gp120 | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
The Journal of infectious diseases, ISSN 1537-6613, 10/2003, Volume 188, Issue 8, pp. 1213 - 1230
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF... 
HIV/AIDS | Inoculation | Viremia | Neutralizing antibodies | Vaccination | Antibodies | Placebos | Viruses | Dosage | Yellow fever | Japanese encephalitis | INFECTIOUS DISEASES | EFFICACY | PROTECTION | MICROBIOLOGY | IMMUNOLOGY | DENGUE | RECOMBINANT | YELLOW-FEVER VACCINE | STRAIN 17D | INFECTION | ANTIBODY-RESPONSE | MONKEYS | ARTHROPOD-BORNE VIRUSES | Yellow Fever Vaccine - administration & dosage | Encephalitis, Japanese - virology | Humans | Vaccines, Inactivated | Viral Vaccines - genetics | Neutralization Tests | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Dose-Response Relationship, Drug | Vaccines, Attenuated - administration & dosage | Immunization Schedule | Japanese Encephalitis Vaccines - administration & dosage | Yellow Fever Vaccine - adverse effects | Double-Blind Method | Yellow Fever Vaccine - immunology | Japanese Encephalitis Vaccines - immunology | West Nile Virus Vaccines | Treatment Outcome | Japanese Encephalitis Vaccines - adverse effects | Encephalitis Virus, Japanese - genetics | Viral Vaccines - administration & dosage | Antigens, Viral - immunology | Vaccines, Attenuated - immunology | Yellow Fever Vaccine - genetics | Animals | Encephalitis, Japanese - prevention & control | Immunologic Memory | Mice | Genetic Vectors | Vaccines, Attenuated - adverse effects | Viral Vaccines - immunology | Encephalitis Virus, Japanese - immunology | Yellow fever virus - genetics | Evaluation | Care and treatment | Clinical trials | Adverse and side effects | Research | Vaccines | Patients | Prevention | Analysis | Causes of | Physiological aspects | Airborne infection | Dosage and administration | Health aspects
Journal Article
Advanced Materials, ISSN 0935-9648, 11/2013, Volume 25, Issue 41, pp. 5928 - 5936
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0199229
.... We searched for domestic reports among HIV-positive persons to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016... 
UNITED-STATES | ADVISORY-COMMITTEE | RISK-FACTORS | VIRUS | AGED 19 YEARS | MULTIDISCIPLINARY SCIENCES | INVASIVE PNEUMOCOCCAL DISEASE | CLINICAL-PRACTICE GUIDELINE | RECOMMENDED IMMUNIZATION SCHEDULE | INFLUENZA VACCINE | INFECTED ADULTS | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Vaccines, Conjugate - adverse effects | Male | HIV - pathogenicity | Viral Vaccines - adverse effects | HIV - drug effects | Measles-Mumps-Rubella Vaccine - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | HIV Infections - immunology | HIV Infections - complications | Adult | Female | Herpesvirus 3, Human - pathogenicity | Vaccines, Attenuated - adverse effects | Drug-Related Side Effects and Adverse Reactions - classification | Influenza vaccines | Complications and side effects | HIV patients | AIDS vaccines | Health aspects | Measles | Health care | Rubella | Sexually transmitted diseases--STD | Vaccination | Disseminated infection | Chicken pox | Medical records | Viruses | Infections | Immune status | Vaccines | Family medical history | Streptococcus infections | Hepatitis | Polysaccharides | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Varicella | Mumps | Antigens | Disease control | CD4 antigen | Zoonoses | Disease prevention | Infectious diseases | Influenza | Medical tests | Adults | Clinical medicine | STD | Sexually transmitted diseases | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 7/2012, Volume 206, Issue 2, pp. 258 - 266
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 1, pp. 62 - 72
Journal Article
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 35, pp. 4477 - 4485
.... The balance between tolerance and immunogenicity remains the main concern in the proof of concept of plant-based vaccine. 
Allergy and Immunology | HIV-1 | Tolerance | VLPs | Vaccine | HBV | Transgenic plants | MEDICINE, RESEARCH & EXPERIMENTAL | transgenic plants | DENDRITIC CELLS | IMMUNODEFICIENCY-VIRUS | GASTROINTESTINAL-TRACT | CD4(+) T-CELLS | B SURFACE-ANTIGEN | IMMUNOLOGY | vaccine | IMMUNE-RESPONSES | VIRUS-LIKE PARTICLES | INFECTION | HEPATITIS-B | tolerance | Vaccines, Edible - administration & dosage | AIDS Vaccines - immunology | Vaccines, DNA - immunology | AIDS Vaccines - adverse effects | Lymphocyte Subsets - immunology | T-Lymphocytes, Regulatory - immunology | Epitopes - immunology | Flow Cytometry | Vaccines, Virosome - immunology | Plants, Genetically Modified | Female | Viral Proteins - biosynthesis | Administration, Oral | Lymphocyte Activation | Vaccines, Virosome - administration & dosage | Hepatitis B Vaccines - administration & dosage | Viral Proteins - genetics | Immunization, Secondary - methods | Lymph Nodes - immunology | Epitopes - genetics | HIV-1 - genetics | Tobacco | Animals | Vaccines, Edible - adverse effects | Vaccines, Edible - immunology | Hepatitis B Vaccines - adverse effects | Vaccines, Virosome - adverse effects | Hepatitis B virus - genetics | Hepatitis B Vaccines - immunology | Mice | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Biological products industry | Genetic engineering | Plants | Vaccines | HIV (Viruses) | T cells | Hepatitis B | Proteins | Metabolites | Lymphocytes | Human immunodeficiency virus--HIV | Rodents | Infections | Flowers & plants | Viral infections | Immune system | Vaccines, DNA | Viral Proteins | CD8-Positive T-Lymphocytes | Life Sciences | Immunization, Secondary | Immunology | T-Lymphocytes, Regulatory | Vaccines, Edible | Hepatitis B virus | Vaccines, Virosome | Epitopes | Lymph Nodes | Vaccinology | Lymphocyte Subsets | Hepatitis B Vaccines | AIDS Vaccines
Journal Article
Vaccine, ISSN 0264-410X, 2007, Volume 25, Issue 20, pp. 4085 - 4092
Abstract Needle-free delivery of a six-plasmid HIV-1 DNA vaccine encoding EnvA, EnvB, EnvC, and subtype B Gag, Pol, and Nef underwent open-label evaluation in 15 subjects... 
Allergy and Immunology | Promoter | Prevention | T cell response | AIDS | Envelope | Gag | Pol | Nef | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | VIRUS | SAFETY | HUMANS | IMMUNOGENICITY EVALUATION | INDUCTION | IMMUNOLOGY | ENV | envelope | promoter | MEMORY T-CELLS | prevention | HIV Infections - prevention & control | Vaccines, DNA - genetics | Gene Products, env - immunology | Humans | AIDS Vaccines - immunology | Vaccines, DNA - immunology | Male | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Vaccines, DNA - administration & dosage | AIDS Vaccines - adverse effects | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV Antibodies - immunology | Plasmids - genetics | HIV Antibodies - biosynthesis | Vaccines, Combined - genetics | Adult | Female | Gene Products, gag - immunology | HIV Infections - virology | Plasmids - immunology | HIV-1 - genetics | Immunity, Cellular - immunology | HIV-1 - immunology | Vaccines, Combined - adverse effects | Vaccines, DNA - adverse effects | Adolescent | AIDS Vaccines - genetics | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Gene Products, nef - immunology | nef Gene Products, Human Immunodeficiency Virus | Proteins | AIDS vaccines | T cells | HIV (Viruses) | DNA | Enzyme-linked immunosorbent assay | Vaccines | Acquired immune deficiency syndrome--AIDS | Plasmids | Laboratories | Human immunodeficiency virus--HIV
Journal Article